FY2026
Effective from
- Code-level rules changed
Type 2 diabetes mellitus without complications
Billable diagnosis code
CDC/NCHS · FY2026type 2 diabetes mellitus, without complications in remission (E11.A)
Coverage depends on the payer, service and applicable policy. A billable code does not guarantee payment.
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
Latest recorded change · FY2026
Effective from
Type 2 diabetes mellitus without complications
Billable diagnosis code
CDC/NCHS · FY2026| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Inherited rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Inherited rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | Code-level rules changed |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical mapping only; not an automatic code substitution.
type 2 diabetes mellitus, without complications in remission (E11.A)
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Other entries in the same category; these are not automatic substitutes.
| Code | Description | Category · further specificity required |
|---|---|---|
| E11.0 | Type 2 diabetes mellitus with hyperosmolarity | Category · further specificity required |
| E11.1 | Type 2 diabetes mellitus with ketoacidosis | Category · further specificity required |
| E11.2 | Type 2 diabetes mellitus with kidney complications | Category · further specificity required |
| E11.3 | Type 2 diabetes mellitus with ophthalmic complications | Category · further specificity required |
| E11.4 | Type 2 diabetes mellitus with neurological complications | Category · further specificity required |
| E11.5 | Type 2 diabetes mellitus with circulatory complications | Category · further specificity required |
| E11.6 | Type 2 diabetes mellitus with other specified complications | Category · further specificity required |
| E11.8 | Type 2 diabetes mellitus with unspecified complications | Billable / specific |
| E11.A | Type 2 diabetes mellitus without complications in remission | Billable / specific |
Official titles and instructions are preserved in their source language. Official sources ↗
Excludes 1 · type 2 diabetes mellitus, without complications not in remission (E11.9)